Chemed Corporation (NYSE: CHE) reported Q2 EPS of $4.71, $0.38 worse than the analyst estimate of $5.09. Revenue for the quarter came in at $554 million versus the consensus estimate of $562.54 million.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.